Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.40% Nasdaq Up0.97%

PharmAthene, Inc. (PIP)

-NYSE MKT
1.41 0.02(1.40%) Apr 22, 4:03PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 22, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$49
Apr 22, 2014New Constructs, LLCN/APIP: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 21, 2014Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - PHARMATHENE INC. (PIP-A)11$25
Apr 20, 2014GlobalDataGlobalDataPharmAthene, Inc. (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile31$250
Apr 18, 2014Wright ReportsN/AWright Investors Service Comprehensive Report for Pharmathene Inc.40$75
Apr 18, 2014Pechala's ReportsFrantisek PechalaPHARMATHENE INC (PIP) 12-months forecast1$15
Apr 18, 2014Reuters Investment ProfileN/APharmAthene Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138
Apr 16, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: ACUR , ANTH , LCI , OMER , PIP , SLXP , TGTX -- DRUGS3$34.50
Apr 16, 2014Ford Investor Services, Inc.N/AValue Graph: PHARMATHENE -- PIP1$11.50
Apr 12, 2014TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: PHARMATHENE INC (PIP)5$10

View All Reports for PIP ...